These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16329150

  • 1. Reduction in tamoxifen-induced CYP3A2 expression and DNA adducts using antisense technology.
    Mahadevan B, Arora V, Schild LJ, Keshava C, Cate ML, Iversen PL, Poirier MC, Weston A, Pereira C, Baird WM.
    Mol Carcinog; 2006 Feb; 45(2):118-25. PubMed ID: 16329150
    [Abstract] [Full Text] [Related]

  • 2. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.
    Schild LJ, Divi RL, Beland FA, Churchwell MI, Doerge DR, Gamboa da Costa G, Marques MM, Poirier MC.
    Cancer Res; 2003 Sep 15; 63(18):5999-6003. PubMed ID: 14522927
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL, Osborne MR, Hewer A, Phillips DH, Poirier MC.
    Cancer Res; 1999 Oct 01; 59(19):4829-33. PubMed ID: 10519392
    [Abstract] [Full Text] [Related]

  • 4. The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy.
    Dehal SS, Brodie AM, Kupfer D.
    Drug Metab Dispos; 1999 Mar 01; 27(3):389-94. PubMed ID: 10064571
    [Abstract] [Full Text] [Related]

  • 5. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.
    Shibutani S, Suzuki N, Laxmi YR, Schild LJ, Divi RL, Grollman AP, Poirier MC.
    Cancer Res; 2003 Aug 01; 63(15):4402-6. PubMed ID: 12907611
    [Abstract] [Full Text] [Related]

  • 6. c-Myc antisense limits rat liver regeneration and indicates role for c-Myc in regulating cytochrome P-450 3A activity.
    Arora V, Knapp DC, Smith BL, Statdfield ML, Stein DA, Reddy MT, Weller DD, Iversen PL.
    J Pharmacol Exp Ther; 2000 Mar 01; 292(3):921-8. PubMed ID: 10688605
    [Abstract] [Full Text] [Related]

  • 7. Inefficient repair of tamoxifen-DNA adducts in rats and mice.
    Kim SY, Suzuki N, Laxmi YR, Shibutani S.
    Drug Metab Dispos; 2006 Feb 01; 34(2):311-7. PubMed ID: 16299164
    [Abstract] [Full Text] [Related]

  • 8. Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.
    Gamboa da Costa G, Marques MM, Fu X, Churchwell MI, Wang YP, Doerge DR, Beland FA.
    Cancer Lett; 2007 Nov 18; 257(2):191-8. PubMed ID: 17765393
    [Abstract] [Full Text] [Related]

  • 9. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
    Darvari R, Boroujerdi M.
    Cancer Chemother Pharmacol; 2005 Nov 18; 56(5):497-509. PubMed ID: 15937726
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen-induced antitumorigenic/antiestrogenic action synergized by a selective aryl hydrocarbon receptor modulator.
    McDougal A, Wormke M, Calvin J, Safe S.
    Cancer Res; 2001 May 15; 61(10):3902-7. PubMed ID: 11358803
    [Abstract] [Full Text] [Related]

  • 11. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus.
    Li D, Dragan Y, Jordan VC, Wang M, Pitot HC.
    Cancer Res; 1997 Apr 15; 57(8):1438-41. PubMed ID: 9108442
    [Abstract] [Full Text] [Related]

  • 12. Formation of tamoxifen-DNA adducts in human endometrial explants exposed to alpha-hydroxytamoxifen.
    Kim SY, Suzuki N, Laxmi YR, McGarrigle BP, Olson JR, Sharma M, Sharma M, Shibutani S.
    Chem Res Toxicol; 2005 May 15; 18(5):889-95. PubMed ID: 15892583
    [Abstract] [Full Text] [Related]

  • 13. Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods.
    Schild LJ, Phillips DH, Osborne MR, Hewer A, Beland FA, Churchwell MI, Brown K, Gaskell M, Wright E, Poirier MC.
    Mutagenesis; 2005 Mar 15; 20(2):115-24. PubMed ID: 15755801
    [Abstract] [Full Text] [Related]

  • 14. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
    Tao X, Piao H, Canney DJ, Borenstein MR, Nnane IP.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):1078-85. PubMed ID: 17045772
    [Abstract] [Full Text] [Related]

  • 15. Determination of tamoxifen--DNA adducts in leukocytes from breast cancer patients treated with tamoxifen.
    Umemoto A, Monden Y, Lin CX, Abdul-Momen M, Ueyama Y, Komaki K, Laxmi YR, Shibutani S.
    Chem Res Toxicol; 2004 Dec 19; 17(12):1577-83. PubMed ID: 15606132
    [Abstract] [Full Text] [Related]

  • 16. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2006 Jan 19; (520):4-246. PubMed ID: 16628245
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer.
    Perumal SS, Shanthi P, Sachdanandam P.
    Cancer Chemother Pharmacol; 2005 Jul 19; 56(1):105-14. PubMed ID: 15726365
    [Abstract] [Full Text] [Related]

  • 18. Mutagenic potential of alpha-(N2-deoxyguanosinyl)tamoxifen lesions, the major DNA adducts detected in endometrial tissues of patients treated with tamoxifen.
    Terashima I, Suzuki N, Shibutani S.
    Cancer Res; 1999 May 01; 59(9):2091-5. PubMed ID: 10232593
    [Abstract] [Full Text] [Related]

  • 19. Accomodation of S-cis-tamoxifen-N(2)-guanine adduct within a bent and widened DNA minor groove.
    Shimotakahara S, Gorin A, Kolbanovskiy A, Kettani A, Hingerty BE, Amin S, Broyde S, Geacintov N, Patel DJ.
    J Mol Biol; 2000 Sep 15; 302(2):377-93. PubMed ID: 10970740
    [Abstract] [Full Text] [Related]

  • 20. Molecular and pharmacokinetic evaluation of rat hepatic and gastrointestinal cytochrome p450 induction by tamoxifen.
    Cotreau MM, von Moltke LL, Harmatz JS, Greenblatt DJ.
    Pharmacology; 2001 Sep 15; 63(4):210-9. PubMed ID: 11729359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.